What is DCGI?
The Drugs Controller General of India (DCGI) is the apex regulatory authority responsible for the approval, licensing and oversight of pharmaceutical products in India. Operating under the Central Drugs Standard Control Organisation (CDSCO), the DCGI ensures that every drug manufactured, imported or distributed in India meets stringent standards of safety, efficacy and quality.
DCGI approval is not simply a licence — it is a rigorous, evidence-based evaluation of a product's clinical data, manufacturing standards and labelling accuracy. Only products that meet every requirement of India's drug regulatory framework are granted approval to reach patients.
REGULATORY FRAMEWORK
What DCGI Governs
The six key areas of pharmaceutical regulation overseen by India's apex drug authority
Drug Approval
Every new drug or formulation must be evaluated and approved by DCGI before it can be manufactured or sold in India — based on safety, efficacy and quality evidence.
Manufacturing Licences
DCGI oversees the licensing of pharmaceutical manufacturing facilities — ensuring that production environments meet the required standards before any product is made.
Clinical Trial Oversight
DCGI regulates all clinical trials conducted in India — setting standards for trial design, patient safety, data integrity and ethical conduct throughout the research process.
Import Regulation
All pharmaceutical products imported into India must meet DCGI standards — protecting the Indian market from substandard or unapproved medicines from overseas.
Labelling Standards
DCGI mandates strict labelling requirements — ensuring every product carries accurate information on composition, dosage, storage, expiry and contraindications for patient safety.
Post-Market Surveillance
DCGI monitors products even after approval — tracking adverse events, quality complaints and market performance to ensure ongoing patient safety post-launch.
Full Regulatory Compliance at Quinek
At Quinek Life Sciences, every product we bring to market operates under full DCGI compliance. This means every formulation has been evaluated, approved and licensed in accordance with India's apex drug regulatory framework — giving doctors, hospitals and patients complete confidence in every product they receive from us.
DCGI compliance at Quinek is not just about getting approval — it is about maintaining it. We work proactively with regulatory requirements, staying current with every update to India's drug laws, labelling standards and post-market obligations so our partners never face regulatory risk.
100% DCGI Approved
Every product fully licensed
Proactive Compliance
Always ahead of regulatory updates
Zero Regulatory Risk
For every doctor and partner
200+ Formulations
All DCGI compliant and approved
"Every Quinek product carries DCGI approval — not because the law requires it, but because our doctors, partners and patients deserve the assurance that comes with India's highest regulatory standard."
— QUINEK LIFE SCIENCES
Approved. Compliant. Trusted across India.
Every Quinek product is fully DCGI approved — because regulatory integrity is non-negotiable.
← Back to Our Quality